Blood Pressure Disorders Drug Development Pipeline Review, 2018 - ResearchByMarkets.com

"Blood Pressure Disorders Drug Development Pipeline Review, 2018"

Summary

This report provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hypertension, pulmonary arterial hypertension (PAH) and hypotension, and features dormant and discontinued products.

Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure. Many factors can affect blood pressure, including hormone levels, water and salt levels in the body and the condition of the kidneys, nervous system, and blood vessels. Most people with high blood pressure have no signs or symptoms, even if blood pressure readings reach dangerously high levels.

Although a few people with early-stage high blood pressure may have dull headaches, dizzy spells or a few more nosebleeds than normal, these signs and symptoms typically do not occur until high blood pressure has reached a severe stage. There are 253 products in development for this indication.

PAH is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms include chest pain, fatigue, passing out suddenly, and swelling of the legs (edema). There are 92 products in development for this indication.

Low blood pressure, or hypotension, occurs when blood pressure during and after each heartbeat is much lower than usual. This means the heart, brain, and other parts of the body do not get enough blood. Symptoms include blurred vision, dizziness, confusion, sleeplessness and weakness. Pipeline activity is much lower for hypotension than for hypertension or PAH with only seven products in development for this indication.

Molecular targets acted on by products in development for blood pressure disorders include angiotensin receptors, tyrosine protein kinases and phosphodiesterases. Companies operating in this pipeline space include Gmax Biopharm, Actelion Pharmaceuticals and Theravance Biopharma.

VIEW DETAILED TOC, COMPANIES MENTIONED AND TABLES/FIGURES:
https://www.researchbymarkets.com/report/blood-pressure-disorders-drug-development-pipeline-review-2018-33713.html

Scope

- Which companies are the most active within the pipeline for blood pressure disorders?
- Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened within this field?

REQUEST A SAMPLE REPORT:
https://www.researchbymarkets.com/sample-request/33713

Reasons to buy

- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.

Companies Mentioned:
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
BCO Pharma Ltd
....and many more.

Get in touch with us:
ResearchByMarkets.com
Ritesh Tiwari, Director
enquiry@researchbymarkets.com
USA: +1-800-416-3124

About Us:

"Research By Markets" is a Market Research Reports Depository. Our Latest Market Research Reports cover a lot of Industry Sectors - Aerospace and Defense, Automotive and Transportation, Chemicals and Materials, Consumer Goods and Services, Energy and Power, Environmental, Food and Beverages, Healthcare, Information Technology, Manufacturing and Construction, Medical Devices, Petroleum, Pharmaceuticals, Semiconductor and Electronics, Telecommunications and more.

We are trusted by Fortune 500 companies for our client centric support. We have helped our clients in procuring research studies as per their requirements and also ensured they get proper post purchase support. We ensure that all our client queries are addressed in quick time.

We strive our best to ensure that our clients have a seamless experience and are happy and smiling every time they do business with us.

https://www.researchbymarkets.com/aboutus

Research By Markets
E/3, Ganga Homes,
Behind Bank Of India,
Viman Nagar,
Pune 411 014.
Maharashtra, India

This release was published on openPR.